AAU - Almaden Announces Extension of Cure Period for NYSE American Listing | Benzinga
VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (("Almaden" or "the Company", TSX:AMM, NYSE:AAU) announces that, further to its press release of April 21, 2023, it has received an extension of its cure deadline from October 19, 2023 to April 19, 2024 ("New Cure Deadline").
As previously announced, Almaden is not in compliance with the continued listing standards of the NYSE American exchange because the Company's securities have been selling for a low price per share for a substantial period of time which NYSE American determines to be a 30-trading-day average price of less than US$0.20 per share. The Company's continued listing on the NYSE American exchange is predicated on it demonstrating sustained price improvement within a reasonable period of time which the staff has determined to be no later than April 19, 2024.
Almaden is considering its alternatives with respect to the requirement that it regain compliance with the NYSE American's continued listing standards within the New Cure Deadline.
On Behalf of the Board of Directors,
"J. Duane Poliquin"
J. Duane Poliquin
Chair
Almaden Minerals Ltd.
Safe Harbor Statement
Certain of the statements and information in this news release constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian provincial securities laws. All statements, other than statements of historical fact, are forward-looking statements or information. Forward-looking statements or information in this news release relate to, among other things, the ...